GEHCV GE HEALTHCARE TECHNOLOGIES INC

GE HealthCare Launches Enhanced Venue Family Point-of-Care Ultrasound Systems Featuring AI-Driven Caption Guidance

GE HealthCare (Nasdaq: GEHC) today announced its Venue Family point-of-care ultrasound systems will now feature Caption Guidance, artificial intelligence (AI)-driven technology that provides real-time guidance to users for capturing diagnostic-quality cardiac images. The Venue Family is the first among GE HealthCare ultrasound products to incorporate this scan guidance technology following the company’s acquisition of Caption Health earlier this year. Caption Guidance is an optional add-on that offers new capabilities at the point of care, supporting clinicians in a wide range of clinical settings and practices such as emergency departments, critical care wards, and anesthesiology.

Cardiac ultrasound examinations, which enable examination of the structure of the heart using sound waves, are the primary tool used to help identify heart failure, the most common diagnosis in the U.S. for hospitalized patients over the age of 65. Heart failure contributes to millions of deaths globally every year.1,2 The AI-driven Caption Guidance technology gives clinicians step-by-step instructions to confidently acquire ultrasound images for cardiac assessments. This can help providers, even those who are not experts in ultrasound, by addressing training and skill barriers to ultrasound usage, thereby expanding ultrasound access. This can potentially enable early detection of signs of heart disease in at-risk patients, which may ultimately help improve clinical outcomes with early intervention to slow disease progression and potentially prevent hospitalizations.

“Venue Family ultrasound systems support clinical decision-making at the point of care, including the emergency department, offering simple, fast and precise solutions. With the integration of Caption Guidance AI-driven software, these devices can enhance cardiac care and reduce the burden on sonographers and radiology departments by giving more clinicians the ability to perform scans and triage patients,” said Dietmar Seifriedsberger, Global General Manager, Point of Care and Handheld Ultrasound at GE HealthCare. “The AI software is expected to increase the number of clinicians who can successfully and confidently conduct cardiac ultrasound scans, which is especially useful in emergency or critical care settings where demand is high and accuracy is essential.”

Caption Guidance on the Venue Family point-of-care ultrasound systems is available in the United States. GE HealthCare plans to integrate this innovative AI technology into other ultrasound systems, including handheld systems, helping to further expand access to diagnostic care as well as the use of ultrasound in a variety of care settings.

“We recognize the potential of Caption Health AI in revolutionizing ultrasound access and have worked quickly to deliver on integrating this promising technology to improve patient care,” said Karley Yoder, Chief Digital Officer, Ultrasound at GE HealthCare. “Within a few months of the Caption Health acquisition, we have successfully launched Caption Guidance as a powerful new guidance tool on our Venue Family ultrasound systems, enabling efficient and confident use of ultrasound at the point of care and strengthening our integrated products and solutions. We remain committed to making an impact with this technology and plan to expand its use to maternal, fetal, and pulmonary diseases.”

Caption Guidance is part of the Verisound suite of technologies formerly known as Ultrasound Digital Solutions. The new Verisound brand brings together GE HealthCare’s existing ultrasound AI and digital workflow solutions as part of a unified platform designed to help clinicians work smarter and more efficiently.

GE HealthCare will debut the Venue Family ultrasound systems featuring Caption Guidance, and the Verisound brand, at the American College of Emergency Physicians (ACEP) Scientific Assembly taking place October 9-12 in Philadelphia. GE HealthCare will also showcase the new Vscan Air SL, a handheld, wireless ultrasound system designed for rapid cardiac and vascular assessments at the point of care.

Caption Guidance and the Verisound brand will also be featured at the American Society of Anesthesiologists (ASA) Annual Meeting taking place October 13-17 in San Francisco.

For more information on Caption Guidance, visit .

About GE HealthCare Technologies Inc.

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are an $18.3 billion business with 50,000 employees working to create a world where healthcare has no limits.

Follow us on , , , , and for the latest news, or visit our for more information.

1 Heart Failure Statistics. Heart Failure Statistics Information - Emory Heart and Vascular Center. (n.d.).

2 Heart Failure Facts & Information. (n.d.).

EN
06/10/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on GE HEALTHCARE TECHNOLOGIES INC

 PRESS RELEASE

GE HealthCare launches AI-driven, patient-friendly Invenia ABUS Premiu...

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) announced the launch of Invenia™ Automated Breast Ultrasound (ABUS) Premium, the latest 3D ultrasound offering advanced artificial intelligence (AI) and innovative features to drive faster*, reproducible supplemental screening and streamline exam readings on patients with dense breasts. Approximately 71% of cancers occur in dense breasts.1 According to studies across the U.S. and Europe, 40% of women2 and 70% of Asian women3 have dense breast tissue, making them four to six times more likely to receive a breast cancer diagnosis.4 Early d...

 PRESS RELEASE

GE HealthCare and NVIDIA reimagine diagnostic imaging with autonomous ...

SAN JOSE, Calif.--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced a collaboration with NVIDIA at GTC 2025, expanding the existing relationship between the two companies to focus on pioneering innovation in autonomous imaging, beginning with autonomous X-ray technologies and autonomous applications within ultrasound. GE HealthCare has been at the forefront of medical technology innovation with a series of “firsts” that date back more than a century, starting with the invention of its X-ray tube, followed by several others including the first handheld ultrasound, first 3D obstetr...

 PRESS RELEASE

GE HealthCare expands invasive cardiology solutions portfolio with Alt...

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced the launch of the AltiX AI.i edition of Mac-Lab™, CardioLab™ and ComboLab™. The AltiX AI.i editions are designed to improve the user experience, elevating workflow in the cardiac catheterization (cath) lab and supporting even the most complex electrophysiology (EP) procedures. These latest editions offer new features that can streamline workflow and enhance interoperability, while upholding strong cybersecurity standards. Cardiovascular disease (CVD) has nearly doubled over the past three decades, affecting more than 500 ...

 PRESS RELEASE

GE HealthCare Advances Its Cloud Strategy by Unveiling the Genesis Por...

LAS VEGAS--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced its new Genesis solutions, a portfolio of cloud enterprise imaging software-as-a-service (SaaS) solutions. Four features will be offered when commercially released – edge, storage, vendor neutral archive and data migration.i These cloud solutions, are designed to help enhance healthcare organizations’ efficiency and precision, streamline workflows, and optimize the use of capital and IT resources. The growing volume and complexity of patient cases are putting increasing pressure on hospitals’ IT systems, driving the ne...

 PRESS RELEASE

GE HealthCare names new president and CEO, China

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC), a leading global healthcare solutions provider, today announced that Yihao Zhang, president and CEO, China, will retire from the company effective July 1, 2025. Will Song, a Johnson & Johnson veteran for over 20 years, has been named GE HealthCare’s new president and CEO, China, and will join the company on April 1, 2025, ahead of leading the region starting July 1 following Yihao’s departure. Yihao’s planned retirement allowed GE HealthCare to purposefully identify and prepare a qualified successor in Will, an exceptional leader with ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch